The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.57
Ask: 0.60
Change: 0.025 (4.35%)
Spread: 0.03 (5.263%)
Open: 0.60
High: 0.60
Low: 0.60
Prev. Close: 0.575
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Oct 2008 10:47

RNS Number : 0328F
Provexis PLC
03 October 2008
 



TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Provexis Plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

no

An event changing the breakdown of voting rights

no

Other (please specify):______________

no

3. Full name of person(s) subject to notification obligation:

City Equities Limited

4. Full name of shareholder(s) (if different from 3):

5. Date of transaction (and date on which the threshold is crossed or reached if different):

2 October 2008

6. Date on which issuer notified:

2 October 2008

7. Threshold(s) that is/are crossed or reached:

3%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

GB00B0923P27

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

30,769,200

Number of voting rights

30,769,200

Number of shares

15,454,200

Number of voting rights

Percentage of voting rights

Direct

15,454,200

Indirect

nil

Direct

1.9%

Indirect

nil

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

Total (A+B)

Number of voting rights

Percentage of voting rights

15,454,200

1.9%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:

10. Name of proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

Shares have been sold to certain clients, with City Equities Limited acting as Principal.

14 Contact name:

Kevin Wallace

15. Contact telephone name:

020 7489 5555

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFSISUDSASELS
Date   Source Headline
27th Oct 20094:35 pmRNSPrice Monitoring Extension
20th Oct 20097:00 amRNSChange of Adviser
15th Oct 200910:46 amRNSResult of General Meeting
12th Oct 20097:00 amRNSProvexis Announces Update on Human Trial
7th Oct 20094:36 pmRNSHolding(s) in Company
2nd Oct 20091:09 pmRNSHolding(s) in Company
29th Sep 200910:00 amRNSPosting of Circular
28th Sep 20092:40 pmRNSHolding(s) in Company
25th Sep 20097:00 amRNSSubscription and Notice of General Meeting
23rd Sep 20099:54 amRNSShare Price Movement
17th Sep 20092:15 pmRNSDirectorate Change
10th Sep 20093:10 pmRNSResult of AGM
8th Sep 200912:33 pmRNSAdditional Listing
3rd Sep 20094:12 pmRNSAdditional Listing
3rd Sep 200912:37 pmRNSHolding(s) in Company
28th Aug 20098:53 amRNSRecent share price increase
26th Aug 20093:08 pmRNSDisposal of Provexis Holding
25th Aug 200910:32 amRNSHolding(s) in Company
25th Aug 200910:27 amRNSHolding(s) in Company
17th Aug 20099:25 amRNSAnnual Financial Report
11th Aug 20094:22 pmRNSHolding(s) in Company
11th Aug 20097:00 amRNSCommencement of Clinical Trial
10th Aug 20099:43 amRNSRecent share price movement
2nd Jul 20094:44 pmRNSHolding(s) in Company
9th Jun 20097:00 amRNSAudited Results Year ended 31 March 2009
28th May 20097:00 amRNSEuropean Health Claim Adoption for Fruitflow
4th Feb 20097:00 amRNSSirco Launch
3rd Feb 200912:39 pmRNSR&D Pipeline Update
3rd Feb 200911:32 amRNSFurther re Agreement
2nd Dec 20087:00 amRNSInterim Results
3rd Oct 200810:47 amRNSHolding(s) in Company
2nd Oct 20083:17 pmRNSDirector/PDMR Shareholding
2nd Oct 200811:08 amRNSResult of AGM
1st Oct 20087:00 amRNSDirectorate Change
16th Sep 20083:22 pmRNSAdditional Listing
11th Sep 20089:49 amRNSAnnual Report and Accounts
2nd Sep 200811:44 amRNSHolding(s) in Company
1st Sep 20085:50 pmRNSGrant of options
1st Sep 200812:57 pmRNSDirectorate Change
29th Aug 20089:32 amRNSHolding(s) in Company
26th Aug 200810:41 amRNSResult of Meeting
21st Aug 20087:00 amRNSJoint Venture Project
4th Aug 20087:00 amRNSProvexis Fundraising
1st Aug 20084:32 pmRNSFinal Results
1st Aug 20084:30 pmRNSPlacing and Share Reorganisat
9th Jun 20084:52 pmRNSResponse to Share Price Movem
27th Mar 200810:07 amRNSHolding(s) in Company
20th Mar 20083:08 pmRNSHolding(s) in Company
3rd Mar 20089:51 amRNSHolding(s) in Company
25th Jan 200810:39 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.